Ординатура / Офтальмология / Английские материалы / Handbook of Pediatric Eye and Systemic Disease_Wright, Spiegel, Thompson_2006

31.Cairns JE, Wilson HP, Walshe JM. “Sunflower cataract” in Wilson’s disease. Br Med J 1969;3:95–96.

32.Cantor LB, Disseler JA, Wilson FM. Glaucoma in the Marteaux– Lamy syndrome. Am J Ophthalmol 1989;108:426–430.

33.Carbone AO, Petrozzi CF. Gaucher’s disease. Case report with stress on eye findings. Henry Ford Hosp Med J 1968;16:55–60.

34.Carmody PJ, Rattazzi MC, Davidson RG. Tay-Sachs disease. The use of tears for the detection of heterozygotes. N Engl J Med 1973;28: 1072–1074.

35.Caruso RC, Kaiser-Kupfer MI, Muenzer J, et al. Electroretinographic findings in the mucopolysaccharidoses. Ophthalmology 1986;93: 1612–1616.

36.Ceuterick C, Martin JJ, Libert J, Farriaux JP. Sanfilippo. A disease in the fetus: comparison with preand postnatal cases. Neuropediatrie 1990;11:176–185.

37.Chan CC, Green WR, Maumenee IH, et al. Ocular ultrastructural studies of two cases of the Hurler syndrome (systemic mucopolysaccharidosis I-H). Ophthalmol Pediatr Genet 1983;2:3–19.

38.Charles SJ, Moore AT, Grant JW, Yates JR. Genetic counseling in X- linked ocular albinism: clinical features of the carrier state. Eye 1992;6:75–79.

39.Charlton KH, Binder PS, Wozniak L, Digby DJ. Pseudodendritic keratitis and systemic tyrosinemia. Ophthalmology 1981;88:355–360.

40.Chijiiwa T, Inomata H, Yamana Y, et al. Ocular manifestations of Hurler–Scheie prototype in two sibs. Jpn J Ophthalmol 1983;27: 54–62.

41.Christiansen SP, Smith TJ, Henslee-Downey PJ. Normal intraocular pressure after a bone marrow transplant in glaucoma associated with mucopolysaccharidosis type I-H. Am J Ophthalmol 1990;109:230– 231.

42.Chu FC, Rodrigues MM, Cogan DG, Barranger JA. The pathology of pingueculae in Gaucher’s disease. Ophthalmic Paediatr Genet 1984; 4:7–11.

43.Cogan DG, Chu FC, Barranger JA, Gregg RE. Macula halo syndrome. Variant of Niemann–Pick disease. Arch Ophthalmol 1983;101:1698– 1700.

44.Cogan DG, Chu FC, Gittinger J, Tychsen L. Fundal abnormalities of Gaucher’s disease. Arch Ophthalmol 1980;98:2202–2203.

45.Cogan DG, Chu FC, Reingold D, et al. Ocular motor signs in some metabolic diseases. Arch Ophthalmol 1981;99:1802–1808.

46.Cogan DG, Federman DD. Retinal involvement with reticuloendotheliosis of unclassified type. Arch Ophthalmol 1964;71:489– 491.

47.Cogan DG, Kuwabara T. Histochemistry of the retina in Tay-Sachs disease. Arch Ophthalmol 1959;61:415–423.

48.Cogan DG, Kuwabara T. Ocular pathology of cystinosis, with particular reference to elusiveness of the corneal crystals. Arch Ophthalmol 1960;63:51–57.

49.Cogan DG, Kuwabara T. The sphingolipidoses and the eye. Arch Ophthalmol 1968;79:437–451.

50.Cogan DG, Kuwabara T, Kolodny E, Driscoll S. Gangliosidoses and the fetal retina. Ophthalmology 1984;91:508–512.

51.Cogan DG, Kuwabara T, Moser H. Metachromatic leukodystrophy. Ophthalmologica 1970;160:2–17.

52.Cogan DG, Kuwabara T, Moser H, et al. Retinopathy in a case of Farber’s lipogranulomatosis. Arch Ophthalmol 1966;75:752– 757.

53.Cogan DG, Kuwabara T, Richardson EP, et al. Histochemistry of the eye in metachromatic leucoencephalopathy. Arch Ophthalmol 1958; 60:397–402.

54.Collins MLZ, Traboulsi EI, Maumenee IH. Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses. Ophthalmology 1990;97:1445–1449.

55.Cordes FC. Galactosemia cataract; a review. Report of a case. Am J Ophthalmol 1960;50:1151–1158.

56.Cordes FC, Hogan MJ. Dysostosis multiplex (Hurler’s disease; lipochondrodysplasia; gargoylism). Report of the ocular findings in five cases, with a review of the literature. Arch Ophthalmol 1942;27: 637–664.

57.Cotlier E. Tay Sachs’ retina: deficiency of acetyl hexosaminidase A. Arch Ophthalmol 1971;86:352–356.

58.Crocker AC, Farber S. Niemann–Pick’s disease: a review of 18 patients. Medicine (Baltim) 1958;37:1–95.

59.Cross HE, Jensen AD. Ocular manifestations in the Marfan syndrome and homocystinuria. Am J Ophthalmol 1973;75:405–420.

60.Culotta VC, Gitlin JD. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3105– 3161.

61.Curran RE, Hedges TR, Boger WP. Loss of accommodation and the near response in Wilson’s disease. J Pediatr Ophthalmol Strabismus 1982;19:157–160.

62.Dangel ME, Tsou B H-P. Retinal involvement of Morquio’s syndrome (MPS IV). Ann Ophthalmol 1985;17:349–354.

63.Danks DM. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited diseases. New York: McGraw-Hill, 1995:2211–2235.

64.Davis DB, Currier FP. Morquio’s disease: Report of two cases. JAMA 1934;102:2173–2176.

65.Davis PL, Baker RS, Piccione RJ. Large recession nystagmus surgery in albinos. Effects on acuity. J Pediatr Ophthalmol Strabismus 1997;34:279–285.

66.deKremer RD, Girorgi I, Agaranna CE, et al. Mucopolysaccharidosis type VII ( -glucuronidase deficiency): a chronic variant with an oligosymptomatic severe skeletal dysplasia. Am J Med Genet 1992; 44:145–152.

67.Del Monte MA, Johnson DL, Cotlier E, et al. Diagnosis of inherited enzymatic deficiencies with tears: Fabry disease. Birth Defects 1976; 12:209–219.

68.Del Monte MA, Maumenee IH, Green WR, Kenyon KR. Histopathology of Sanfilippo’s syndrome. Arch Ophthalmol 1983;101:1255– 1262.

69.DeMeirleir LJ, Taylor MJ, Logan WJ. Multimodal evoked potential studies in leukodystrophies of children. Can J Neurol Sci 1988;15: 26–31.

70.Desnick RJ, Ioannou YA, Eng CM. -Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet Al, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995:2741–2784.

71.Desnick RJ, Ioannou YA, Eng CM. -Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3733–3774.

72.Diether S, Schaffer F. Local changes in eye growth induced by imposed local refractive error despite active accommodation. Vision Res 1997;37:659–668.

73.DiFerrante N, Hyman BH, Klish W, et al. Mucopolysaccharidosis VI (Maroteaux–Lamy disease): clinical and biochemical study of a mild variant case. Johns Hopkins Med J 1974;135:42–53.

74.Dingle J, Havener WH. Ophthalmoscopic changes in a patient with Wilson’s disease during long-term penicillamine therapy. Ann Ophthalmol 1978;10:1227–1230.

75.Dolman CL, Chang E, Duke RJ. Pathologic findings in Sandhoff disease. Arch Pathol 1973;96:272–275.

76.Dom R, Brucher JM, Ceuterick C, et al. Adult ceroid-lipofuscinosis (Kufs’ disease) in two brothers. Retinal and visceral storage in one; diagnostic muscle biopsy in the other. Acta Neuropathol 1979;45:67.

77.East T, Savin LH. A case of Gaucher’s disease with biopsy of the typical pingueculae. Br J Ophthalmol 1940;24:611–613.

78.Ellis RWB, Sheldon W, Capone NB. Gargoylism (chondroosteodystrophy, corneal opacities, hepatosplenomegaly, and mental deficiency). Q J Med 1936;29:119–135.

79.Elman MJ, Miller MT, Matalon R. Galactokinase activity in patients with idiopathic cataracts. Ophthalmology 1986;93:210–215.

80.Emery JM, Green WR, Huff DS. Krabbe’s disease. Histopathology and ultrastructure of the eye. Am J Ophthalmol 1972;74:400–405.

81.Emery JM, Green WR, Huff DS, et al. Niemann–Pick disease (type C). Histopathology and ultrastructure. Am J Ophthalmol 1972;74: 1144–1154.

82.Emery JM, Green WR, Wyllie RG, Howell RR. GM1-gangliosidosis. Ocular and pathological manifestations. Arch Ophthalmol 1971;85: 177–187.

83.Erduran E, Mocan H, Gedik Y, et al. Hydrocephalus, corneal opacities, deafness, left ventricle hypertrophy, clinodactyly in an adoles-

cent patient. A new syndrome associated with glucocerebrosidase deficiency. Genet Counsel 1995;6:211–215.

84.Erikson A, Wahlberg I. Gaucher disease: Norrbottnian type. Ocular abnormalities. Acta Ophthalmol 1985;63:221–225.

85.Ferreira RC, Heckenlively JR, Menkes JH, Bateman B. Menkes disease. New ocular and electroretinographic findings. Ophthalmology 1998;105:1076–1078.

86.Filling-Katz MR, Fink JK, Gorin MB, et al. Ophthalmologic manifestations of type B Niemann-Pick disease. Metab Pediatr Syst Ophthalmol 1992;15:16–20.

87.Fitzgerald K, Cibis GW. The value of flash visual evoked potentials in albinism. J Pediatr Ophthalmol Strabismus 1994;31:18–25.

88.Fonda G, Thomas H, Gore GV. Educational and vocational placement, and low-vision corrections in albinism. A report based on 253 patients. Sight Sav Rev 1971;41:29–36.

89.Font RL, Fine BS. Ocular pathology in Fabry’s disease. Histochemical and electron microscopic observations. Am J Ophthalmol 1972; 73:419–430.

90.Frazier PD, Wong VG. Cystinosis. Histologic and crystallographic examination of crystals in eye tissues. Arch Ophthalmol 1968;80:87– 91.

91.Franceschetti AT. Fabry disease: ocular manifestations. Birth Defects 1976;12:195–208.

92.Fulcher T, O’Keefe M, Bowell R, et al. Intellectual and educational attainment in albinism. J Pediatr Ophthalmol Strabismus 1995;32: 368–372.

93.Fulton AB, Albert DM, Craft JL. Human albinism. Light and electron microscopy study. Arch Ophthalmol 1978;96:305–310.

94.Gahl WA, Kaiser-Kupfer MI. Complications of nephropathic cystinosis after renal failure. Pediatr Nephrol 1987;1:260–268.

95.Gahl WA, Thoene JG, Schneider JA. Cystinosis. A disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:5085–5108.

96.Garner A. Ocular pathology of GM2 gangliosidosis, type 2 (Sandhoff disease). Br J Ophthalmol 1973;57:514–520.

97.Ghosh M, McCulloch C. The Morquio syndrome: light and electron microscopic findings from two corneas. Can J Ophthalmol 1974;9: 445–452.

98.Gills JB, Hobson R, Hanley B, et al. Electroretinography and fundus oculi findings in Hurler’s disease and allied mucopolysaccharidoses. Arch Ophthalmol 1965;74:596–603.

99.Goebel HH, Busch-Hettwer H, Bohl J. Ultrastructural study of the retina in late infantile metachromatic leukodystrophy. Ophthalmic Res 1992;24:103–109.

100.Goebel HH, Fix JD, Zeman W. The fine structure of the retina in neuronal ceroid-lipofuscinosis. Am J Ophthalmol 1974;77:25– 39.

101.Goebel HH, Fix JD, Zeman W. Retinal pathology in GM1 gangliosidosis type II. Am J Ophthalmol 1973;75:434–441.

102.Goebel HH, Shimokawa K, Argyrakis A, et al. The ultrastructure of the retina in adult metachromatic leukodystrophy. Am J Ophthalmol 1978;85:841–849.

103.Goldberg MF, Scott CI, McKusick VA. Hydrocephalus and papilledema in the Maroteaux–Lamy syndrome (mucopolysaccharidosis type VI). Am J Ophthalmol 1970;69:969–975.

104.Goldberg MF, von Noorden GK. Ophthalmologic findings in Wilson’s hepatolenticular degeneration with emphasis on ocular motility. Arch Ophthalmol 1966;75:162–170.

105.Goldsmith LA, Kang E, Bienfang DC, et al. Tyrosinemia with plantar and palmar keratosis and keratitis. J Pediatr 1973;83:798–805.

106.Goldsmith LA, Reed J. Tyrosine-induced eye and skin lesions. A treatable genetic disease. JAMA 1976;236:382–384.

107.Goldstein I, Wexler D. Niemann–Pick’s disease with cherry-red spots in the macula. Ocular pathology. Arch Ophthalmol 1931;5:704–716.

108.Goldstein NP, Hollenhorst RW, Randall RV, Gross JB. Possible relationship of optic neuritis, Wilson’s disease, and DL-penicillamine therapy. JAMA 1966;196:734–735.

109.Gravel RA, Clarke JTR, Kaback MM, et al. The GM2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGrawHill, 1995:2839–2879.

110.Gravel RA, Kaback MM, Proia RL, et al. The GM2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGrawHill, 2001:3827–3876.

111.Grover WD, Naiman JL. Progressive paresis of vertical gaze in lipid storage disease. Neurology 1971;21:896–899.

112.Grover WD, Tucker SH, Wenger DA. Clinical variation in two related children with neuronopathic Gaucher’s disease. Ann Neurol 1978;3:281–283.

113.Guerra WF, Verity A, Fluharty AL, et al. Multiple sulfatase deficiency: clinical neuropathological, ultrastructural and biochemical studies. J Neuropathol Exp Neurol 1990;41:406–423.

114.Guillery RW. Normal and abnormal visual field maps in albinos. Central effects on non-matching maps. Ophthalmic Paediatr Genet 1990;11:177–183.

115.Gullingsrud EO, Krivit W, Summers CG. Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation. Longer follow-up. Ophthalmology 1998;105:1099–1105.

116.Guo S, Reinecke RD, Fendick M, Calhoun JH. Visual pathway abnormalities in albinism and infantile nystagmus. VECPs and stereoacuity measurements. J Pediatr Ophthalmol Strabismus 1989; 26:97–104.

117.Harbord M, Buncic R, Chuang SA, et al. Multiple sulfatase deficiency with early severe retinal degeneration. J Child Neurol 1991;6:229–235.

118.Harcourt B, Ashton N. Ultrastructure of the optic nerve in Krabbe’s leukodystrophy. Br J Ophthalmol 1973;57:885–891.

119.Harcourt RB, Dobbs RH. Ultrastructure of the retina in Tay–Sachs disease. Br J Ophthalmol 1968;52:898–902.

120.Harris CN, Shawkat F, Russell-Eggitt I, et al. Intermittent horizontal saccade failure (ocular motor apraxia) in children. Br J Ophthalmol 1996;80:151–158.

121.Heidemann DG, Dunn SP, Bawle EV, Shepherd DM. Early diagnosis of tyrosinemia type II. Am J Ophthalmol 1989;107:559–560.

122.Higgins JJ, Patterson MC, Dambrosia JN, et al. A clinical staging classification for type C Niemann–Pick disease. Neurology 1992;42: 2286–2290.

123.Ho PC, Feman SS. Internuclear ophthalmoplegia in Fabry’s disease. Ann Ophthalmol 1981;13:949–951.

124.Hofmann SL, Peltonen L. The neuronal ceroid lipofuscinoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3877–3894.

125.Hogan MJ, Cordes FC. Lipochondrodystrophy (dysostosis multiplex: Hurler’s disease): pathologic changes in the cornea in three cases. Arch Ophthalmol 1944;32:287–295.

126.Holton JB, Walter JH, Tyfield LA. Galactosemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001: 1553–1587.

127.Howes EL, Wood IS, Golbus M, et al. Ocular pathology of infantile Niemann–Pick disease. Study of a fetus of 23 weeks’ gestation. Arch Ophthalmol 1975;93:494–500.

128.Huang Y, Bron AJ, Meek KM, et al. Ultrastructural study of the cornea in a bone marrow-transplanted Hurler syndrome patient. Exp Eye Res 1996;62:377–387.

129.Hunziker N. Richner–Hanhart syndrome and tyrosinemia type II. Dermatologica 1980;160:180.

130.Iwamoto M, Nawa Y, Maumenee IH, et al. Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidoses IV A). Graefe’s Arch Ophthalmol 1990;228:342–349.

131.Jampel RS, Quaglio ND. Eye movements in Tay–Sachs disease. Neurology 1964;14:1013–1019.

132.Jensen OA. Mucopolysaccharidosis type III (Sanfilippo’s syndrome): Histochemical examination of the eyes and brain with a survey

of the literature. Acta Pathol Microbiol Scand 1971;78:257– 273.

133.Kaiden JS, Schecter R, Bader BF, et al. Angle-closure glaucoma in a patient with Hunter’s syndrome. J Ocul Ther Surg 1982;1:250– 252.

134.Kaiser-Kupfer M, Caruso RC, Minkler DS, Gahl WA. Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol 1986;104:706–711.

135.Kaiser-Kupfer MI, Fujikawa L, Kuwabara T, et al. Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med 1987;316:775–779.

136.Kaiser-Kupfer MI, Gazzo MA, Datiles MB, et al. A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. Arch Ophthalmol 1990;108:689–693.

137.Kajii T, Matsuda K, Ohsawa T, et al. Hurler/Scheie genetic compound (mucopolysaccharidosis IH/IS) in Japanese brothers. Clin Genet 1974;6:394–400.

138.Kasman B, Kuprecht KW. Might the refractive state in oculocutaneous albinism patients be a clue for distinguishing between tyrosi- nase-positive and tyrosinase-negative forms of oculocutaneous albinism? Ger J Ophthalmol 1997;5:422–427.

139.Katz B, Melles B, Schneider JA. Corneal sensitivity in nephropathic cystinosis. Am J Ophthalmol 1987;104:413–416.

140.Katz B, Melles RB, Schneider JA. Glare disability in nephropathic cystinosis. Arch Ophthalmol 1987;105:1670–1671.

141.Keane JR. Lid-opening apraxia in Wilson’s disease. J Clin NeuroOphthalmol 1988;8:31–33.

142.Kenyon KP, Sensenbrenner JA. Electron microscopy of cornea and conjunctiva in childhood cystinosis. Am J Ophthalmol 1974;78: 68–76.

143.Kenyon KP, Quigley HA, Hussels IE, et al. The systemic mucopolysaccharidoses: ultrastructural and histochemical studies of conjunctiva and skin. Am J Ophthalmol 1972;73:811–833.

144.Kenyon KP, Topping TM, Green WR, et al. Ocular pathology of the Maroteaux–Lamy syndrome (systemic mucopolysaccharidosis type VI): histologic and ultrastructural report of two cases. Am J Ophthalmol 1972;73:718–741.

145.King RA, Hearing VJ, Creel DJ, Oetting WS. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001: 5587–5627.

146.King RA, Lewis RA, Townsend DeW, et al. Brown oculocutaneous albinism. Clinical, ophthalmological, and biochemical characterization. Ophthalmology 1985;92:1496–1505.

147.King RA, Olds DP. Hairbulb tyrosinase activity in oculocutaneous albinism. Suggestions for pathway control and block location. Am J Med Genet 1985;20:49–55.

148.Kinnear PE, Jay B, Witkop CJ. Albinism. Survey Ophthalmol 1985; 30:75–101.

149.Kirkham TH, Kanin DF. Slow saccadic eye movements in Wilson’s disease. J Neurol Neurosurg Psychiatry 1974;37:191– 194.

150.Kivlin JD, Sanborn GE, Myers GG. The cherry-red spot in Tay–Sachs and other storage diseases. Ann Neurol 1985;17:356–360.

151.Kolodny EH, Fluharty AL. Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis. In: Scriver CR, Beaudet

AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995;2693–2739.

152.Koshenoja M, Suvanto E. Gargoylism: report of adult form with glaucoma in two sisters. Acta Ophthalmol 1959;37:234–240.

153.Kriss A, Russel-Eggitt I, Harris CM, et al. Aspects of albinism. Ophthalmic Paediatr Genet 1992;13:89–100.

154.Krivit W. Maroteaux–Lamy syndrome (mucopolysaccharidosis type VI). Treatment by allogenic bone marrow transplantation in 6 patients and potential for autotransplantation bone marrow gene insertion. Int Pediatr 1992;7:42–52.

155.Kromberg JGR, Castle DJ, Zwane EM, et al. Red or rufous albinism in Southern Africa. Ophthalmic Paediatr Genet 1990;11:229–235.

156.Larkin DFP, O’Donoghue HN. Developmental glaucoma in oculocutaneous albinism. Ophthalmic Paediatr Genet 1988;9:1–4.

157.Larson HW, Ehlers N. Ocular manifestations in Tay–Sachs’ and Niemann–Pick disease. Acta Ophthalmol 1965;43:286–293.

158.Lavery MA, Green WR, Jabs EW, et al. Ocular histopathology and ultrastructure of Sanfilippo’s syndrome, type III-B. Arch Ophthalmol 1983;101:1263–1274.

159.Lee KA, King RA, Summers CG. Stereopsis in patients with albinism. Clinical correlates. J Am Assoc Pediatr Ophthalmol Strabismus 2001;5:98–104.

160.Levy HL, Brown AE, Williams SE, deJuan E. Vitreous hemorrhage as an ophthalmic complication of galactosemia. J Pediatr 1996;129: 922–925.

161.Levy NS, Dawson WW, Rhodes BJ, et al. Ocular abnormalities in Menkes’ kinky-hair syndrome. Am J Ophthalmol 1974;77:319–325.

162.Levy NS, Krill AE, Beutler E. Galactokinase deficiency and cataracts. Am J Ophthalmol 1972;74:41–48.

163.Libert J, Danis P. Diagnosis of type A, B and C Niemann-Pick disease by conjunctival biopsy. J Submicrosc Cytol 1979;11:143–157.

164.Libert J, Tondeur M, Van Hoof F. The use of conjunctival biopsy and enzyme analysis in tears for the diagnosis of homozygotes and heterozygotes with Fabry disease. Birth Defects 1976;12:221– 239.

165.Libert J, Toussaint D, Guiselings R. Ocular findings in Niemann– Pick disease. Am J Ophthalmol 1975;80:1991–1002.

166.Libert J, Van Hoof F, Toussaint D, et al. Ocular findings in metachromatic leukodystrophy. An electron microscopic and enzyme study in different clinical and genetic variants. Arch Ophthalmol 1979;97: 1495–1504.

167.Macrae WG, Ghosh M, McCulloch C. Corneal changes in Fabry’s disease: a clinico-pathologic case report of a heterozygote. Ophthalmic Pediatr Genet 1985;5:213–218.

168.Martyn LJ. Unpublished personal observations.

169.Matthews JD, Weiter JJ, Kolodny EH. Macular halos associated with Niemann–Pick type B disease. Ophthalmology 1986;93:933– 937.

170.McDonnell JM, Green WR, Maumenee IH. Ocular histopathology of systemic mucopolysaccharidosis, type II-A (Hunter syndrome, severe). Ophthalmology 1985;92:1772–1779.

171.McKeran RO, Bradbury P, Taylor D, Stern G. Neurological involvement in type 1 (adult) Gaucher’s disease. J Neurol Neurosurg Psychiatry 1985;48:172–175.

172.Melles RB, Schneider JA, Rao NA, Katz B. Spatial and temporal sequence of corneal crystal deposition in nephropathic cystinosis. Am J Ophthalmol 1987;104:598–604.

173.Menkes JH, O’Brien JS, Okada S, et al. Juvenile GM2 gangliosidosis. Biochemical and ultrastructural studies on a new variant of Tay–Sachs disease. Arch Neurol 1971;25:14:22.

174.Merin S, Livni N, Yatziv S. Conjunctival ultrastructure in Niemann– Pick disease type C. Am J Ophthalmol 1980;90:708–714.

175.Miller JD, McCluer R, Kanfer JN. Gaucher’s disease. Neurologic disorder in adult siblings. Ann Intern Med 1973;78:883–887.

176.Mitchell GA, Grompe M, Lambert M, Tanguay RM. Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited diseases. New York: McGraw-Hill, 2001:1777–1805.

177.Moser HW. Ceramide deficiency: Farber lipogranulomatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995:2589–2599.

178.Moser HW, Linke T, Fensom AH, et al. Acid ceramidase deficiency. Farber lipogranulomatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:3573–3588.

179.Mudd HS, Levy HL, Krause JP. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 2001:2007–2056.

180.Mullaney P, Abdulaziz HA, Millar L. Glaucoma in mucopolysaccharidosis I-H/S. J Pediatr Ophthalmol Strabismus 1996;33:127–132.

181.Mungen N, Nischal KK, Heon E, et al. Ultrasound biomicroscopy of the eye in cystinosis. Arch Ophthalmol 2000;118:1329–1333.

182.Musarella MA, Raab EL, Rudolph SH, et al. Oculomotor abnormalities in chronic GM2 gangliosidosis. J Pediatr Ophthalmol Strabismus 1982;19:80–89.

183.Naidu S, Hofmann KJ, Moser HW, et al. Galactosylceramide - galactosidase deficiency in association with cherry-red spot. Neuropediatrics 1988;19:46–48.

184.Narita AS, Russell-Eggitt II. Bilateral epiretinal membranes; a new finding in Hunter syndrome. Ophthalmic Genet 1996;17:75–78.

185.Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, et al. (eds) The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995: 2465–2494.